Gliquidone improves retinal injury to relieve diabetic retinopathy via regulation of SIRT1/Notch1 pathway

BACKGROUND: Diabetic retinopathy (DR) is a common and potentially devastating microvascular complication of diabetes mellitus (DM). The main features of DR are inflammation and oxidative damage. Gliquidone (GLI) is confirmed to be a hypoglycemic drug by oral administration. The current study is aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Mengdan, Zhang, Lijun, Sun, Shasha, Zhang, Zhenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711144/
https://www.ncbi.nlm.nih.gov/pubmed/34961513
http://dx.doi.org/10.1186/s12886-021-02215-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711144/
https://www.ncbi.nlm.nih.gov/pubmed/34961513
http://dx.doi.org/10.1186/s12886-021-02215-8

Ejemplares similares